Medicaments
AssigneeGlaxo Group Limited
InventorsRachel Akehurst, Anthony Taylor, David Wyatt
Life of this patent
Estimating the term…
Abstract
This invention relates to aerosol formulations of use for the administration of medicaments by inhalation, in particular a pharmaceutical aerosol formulation which comprises particulate salbutamol and physiologically acceptable salts and solvates thereof and a fluorocarbon or hydrogen-containing chlorofluorocarbon propellant, which formulation is substantially free of surfactant. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of a pharmaceutical aerosol formulation as defined is also described.
Claims25
1-17. (canceled)
A process for preparing a filled pharmaceutical aerosol canister which comprises:
- (a) preparing a pharmaceutical aerosol formulation for use for the administration of medicaments by inhalation characterised in that the formulation comprises particulate fluticasone propionate as medicament and 1,1,1,2-tetrafluoroethane as propellant, which formulation contains no significant amounts of surfactant;
- and
- (b) filling the formulation into a canister.
Dependencies are inferred from the claim text.